Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Preventing Contamination in Granules Production

Posted on By

SOP for Preventing Contamination in Granules Production

Standard Operating Procedure for Preventing Contamination in Granules Production

1) Purpose

The purpose of this SOP is to establish procedures to prevent contamination during granules production in the pharmaceutical industry, ensuring product quality and safety.

2) Scope

This SOP applies to all personnel involved in granules production processes within the pharmaceutical manufacturing facility.

3) Responsibilities

Production Supervisors: Responsible for implementing contamination prevention measures.
Quality Assurance (QA) Department: Responsible for monitoring and auditing contamination control procedures.
Operators and Technicians: Responsible for adhering to contamination prevention protocols during operations.

4) Procedure

  1. Facility Design and Layout:
    1. Design production areas with separate zones for different process stages (e.g., raw material handling, processing, packaging).
    2. Implement controlled access and air handling systems to minimize contamination risks.
  2. Personnel Hygiene:
    1. Enforce strict gowning and hygiene practices for personnel entering production areas.
    2. Provide training on contamination prevention and aseptic techniques.
  3. Equipment Cleaning and Maintenance:
    1. Develop and follow cleaning procedures for equipment used in granules production.
    2. Regularly inspect and maintain equipment to prevent contamination risks.
  4. Material Handling:
    1. Store and handle raw materials in a manner that prevents contamination.
    2. Use dedicated tools and equipment for each material to prevent cross-contamination.
  5. Environmental Monitoring:
    1. Conduct regular monitoring of air quality, particulate levels, and microbial contamination in production areas.
    2. Take corrective actions based on monitoring results to maintain cleanliness and
prevent contamination.
  • Documentation and Records:
    1. Maintain comprehensive records of contamination prevention activities, including cleaning logs and environmental monitoring reports.
    2. Review and update procedures based on audit findings and regulatory requirements.
  • 5) Abbreviations, if any

    SOP: Standard Operating Procedure
    QA: Quality Assurance

    6) Documents, if any

    Cleaning Procedures, Facility Layout Plans, Contamination Control Logs

    7) Reference, if any

    Good Manufacturing Practice (GMP) guidelines for pharmaceutical manufacturing.

    8) SOP Version

    Version 1.0

    See also  SOP for Dry Granulation
    Powder & Granules Tags:analytical method development granules, assay of active ingredient granules, bulk density testing granules, contamination prevention powder, documentation in powder manufacturing, equipment cleaning for powders, final product inspection powder, flowability testing powders, formulation development granules, granulation stability testing, granule calibration SOP, granule production procedure, granule quality control SOP, homogeneity testing granules, in-process testing granules, microbial testing powder, particle size distribution powders, pharmaceutical powder handling, powder blending protocol, powder manufacturing SOP, powder packaging guidelines, powder storage conditions, process optimization powders, process validation powders, raw material inspection powders, sample collection for powders, SOP for granulation techniques, sterility in granule production, training SOP for granule production, waste disposal in granule production

    Post navigation

    Previous Post: Injectables: SOP for Validation Master Plan Preparation and Approval
    Next Post: SOP for Formulation Development for MDIs

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version